Clinical Trial Update: Pilot Study of Neo-Adjuvant Everolimus to Treat Advanced Renal Cell Carcinoma - Analysis of Biomarkers [NA]

View source ↗

Summary

A completed pilot study evaluating neoadjuvant everolimus for advanced renal cell carcinoma, including biomarker analyses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (Afinitor) (everolimus)

Snippet

Sponsor: St. Joseph's Healthcare Hamilton | Conditions: Carcinoma, Renal Cell | NA | Status: COMPLETED